|
FR2505657A1
(fr)
|
1981-05-13 |
1982-11-19 |
Pasteur Institut |
Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
|
|
US5626851A
(en)
|
1987-11-30 |
1997-05-06 |
The Wistar Institute Of Anatomy And Biology |
Rotavirus reassortant vaccine
|
|
US5096885A
(en)
|
1988-04-15 |
1992-03-17 |
Genentech, Inc. |
Human growth hormone formulation
|
|
DE69029765T2
(de)
|
1989-07-24 |
1997-05-15 |
Bayer Ag |
Stabilisierung von hochgereinigten Proteinen
|
|
ES2188593T3
(es)
|
1992-03-24 |
2003-07-01 |
United Cancer Res Inst |
Vacuna que contiene un virus vivo.
|
|
AU2088992A
(en)
|
1992-05-05 |
1993-11-11 |
Research Foundation For Microbial Diseases Of Osaka University, The |
Stabilized live vaccine
|
|
CA2158935A1
(en)
|
1993-10-12 |
1995-04-20 |
Chiron Viagene, Inc. |
Methods for preserving recombinant viruses
|
|
ES2264126T3
(es)
|
1994-05-16 |
2006-12-16 |
MERCK & CO., INC. |
Vacunas contra el papilomavirus.
|
|
WO1996001651A1
(en)
|
1994-07-11 |
1996-01-25 |
The Government Of The United States Of America, Represented By The Department Of Health And Human Services |
Attenuated human rotavirus vaccine
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US6165773A
(en)
|
1995-10-25 |
2000-12-26 |
Provalis Uk Limited |
Methods of preserving viruses
|
|
GB9521806D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Preservation methods
|
|
FR2742756B1
(fr)
|
1995-12-22 |
1998-04-03 |
Pasteur Merieux Serums Vacc |
Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
|
|
FR2751343B1
(fr)
|
1996-07-16 |
1998-12-18 |
Transgene Sa |
Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
|
|
DE69738271T2
(de)
|
1996-09-26 |
2008-08-28 |
Merck & Co., Inc. |
Rotavirus-impfstoff
|
|
US6403098B1
(en)
|
1996-09-26 |
2002-06-11 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US5932223A
(en)
*
|
1996-09-26 |
1999-08-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US6616931B1
(en)
|
1996-09-26 |
2003-09-09 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US20080261289A1
(en)
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
US6290967B1
(en)
|
1996-12-20 |
2001-09-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized vaccines
|
|
US6051238A
(en)
|
1996-12-20 |
2000-04-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized mumps vaccines
|
|
AU725231B2
(en)
|
1996-12-20 |
2000-10-12 |
Merck & Co., Inc. |
Stabilisers for lyophilised vaccines
|
|
US6565831B1
(en)
*
|
1999-02-24 |
2003-05-20 |
Oncolytics Biotech Inc. |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
|
|
KR100918187B1
(ko)
*
|
1998-02-17 |
2009-09-22 |
쉐링 코포레이션 |
바이러스를 포함하는 조성물 및 바이러스 제제의 농축방법
|
|
GB9808922D0
(en)
|
1998-04-24 |
1998-06-24 |
Cantab Pharmaceuticals Res Ltd |
Virus preparations
|
|
CN100387300C
(zh)
|
1998-07-28 |
2008-05-14 |
由卫生与公众服务部代表的美利坚合众国 |
多价人-牛轮状病毒疫苗
|
|
CN1062770C
(zh)
*
|
1998-11-12 |
2001-03-07 |
卫生部长春生物制品研究所 |
甲肝-麻疹二联疫苗及其生产方法
|
|
US6689600B1
(en)
*
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
EP1133316B1
(en)
|
1998-11-16 |
2009-01-21 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6225289B1
(en)
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
WO2000061184A2
(en)
|
1999-04-08 |
2000-10-19 |
Glenn Gregory M |
Dry formulation for transcutaneous immunization
|
|
US6592869B2
(en)
|
1999-08-24 |
2003-07-15 |
Teva Pharmaceutical Industries, Ltd. |
Vaccine composition and method of using the same
|
|
AU779403B2
(en)
|
1999-08-24 |
2005-01-20 |
Teva Pharmaceutical Industries Ltd. |
A vaccine composition and method of using the same
|
|
DE60025019T2
(de)
|
1999-10-29 |
2006-08-24 |
Nektar Therapeutics, San Carlos |
Trockenpulverzusammensetzungen mit verbesserter dispersivität
|
|
EP2420247A1
(en)
|
2000-03-07 |
2012-02-22 |
Merck Sharp & Dohme Corp. |
Adenovirus formulations
|
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
US20020120228A1
(en)
|
2000-06-08 |
2002-08-29 |
Yuh-Fun Maa |
Powder compositions
|
|
CA2412197A1
(en)
|
2000-06-08 |
2001-12-13 |
Powderject Vaccines, Inc. |
Powder compositions
|
|
US6689353B1
(en)
*
|
2000-06-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Stabilized interleukin 2
|
|
TWI289158B
(en)
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
GB0020089D0
(en)
|
2000-08-15 |
2000-10-04 |
Smithkline Beecham Biolog |
Vaccine Composition
|
|
ATE434035T1
(de)
|
2000-09-25 |
2009-07-15 |
Polymun Scient Immunbio Forsch |
Lebender influenza impfstoff und verfahren zu seiner herstellung
|
|
US20040033239A1
(en)
|
2001-03-06 |
2004-02-19 |
Evans Robert K |
Adenovirus formulations
|
|
IL157304A0
(en)
|
2001-03-16 |
2004-02-19 |
Oncolytics Biotech Inc |
Method of extracting virus from cell culture
|
|
AU2002302814A1
(en)
|
2001-06-08 |
2002-12-23 |
Powderject Vaccines, Inc. |
Spray freeze-dried compositions
|
|
GB0124710D0
(en)
|
2001-10-15 |
2001-12-05 |
Quadrant Healthcare Uk Ltd |
Therapeutic composition
|
|
BR0214280A
(pt)
|
2001-11-19 |
2005-01-11 |
Becton Dickinson Co |
Composição farmacêuticas em forma particulada
|
|
CA2469491A1
(en)
|
2001-12-12 |
2003-06-19 |
Kerrie Setiawan |
Composition for viral preservation
|
|
US20030153065A1
(en)
|
2002-01-14 |
2003-08-14 |
Genvec, Inc. |
Composition and method for maintaining non-enveloped viral vectors
|
|
US20030232018A1
(en)
*
|
2002-01-18 |
2003-12-18 |
Berlex Biosciences |
Stabilized formulations of adenovirus
|
|
EP1494651A4
(en)
|
2002-04-11 |
2010-10-13 |
Medimmune Vaccines Inc |
PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
|
|
US20040042972A1
(en)
|
2002-04-11 |
2004-03-04 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
|
WO2003087339A2
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for pulmonary administration
|
|
DE60327069D1
(de)
|
2002-04-30 |
2009-05-20 |
Oncolytics Biotech Inc |
Verbesserte reinigungsmethode für viren
|
|
CA2503871C
(en)
|
2002-11-01 |
2012-12-11 |
Glaxosmithkline Biologicals S.A. |
An immunogenic composition for generating an immune response against polio virus
|
|
US6752740B2
(en)
|
2002-11-12 |
2004-06-22 |
Jeffery T. Semmes |
Continuously variable transmission
|
|
KR20050088175A
(ko)
|
2002-12-17 |
2005-09-02 |
메드이뮨 백신즈 인코포레이티드 |
생물활성 물질의 고압 분무 건조
|
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
|
US20060257852A1
(en)
|
2003-04-10 |
2006-11-16 |
Chiron Corporation |
Severe acute respiratory syndrome coronavirus
|
|
MXPA06002459A
(es)
|
2003-09-02 |
2006-06-20 |
Glaxosmithkline Biolog Sa |
Vacuna.
|
|
WO2005052116A2
(en)
|
2003-11-19 |
2005-06-09 |
Merck & Co., Inc. |
Preservative-containing virus formulations
|
|
ES2536322T3
(es)
|
2003-12-17 |
2015-05-22 |
Wyeth Llc |
Procedimiento para producir composiciones de VSR estables en almacenamiento
|
|
WO2005066333A1
(en)
|
2003-12-30 |
2005-07-21 |
Aventis Pasteur, Inc. |
Stabilizing compositions for recombinant viruses
|
|
GB0404586D0
(en)
|
2004-03-01 |
2004-04-07 |
Britannia Pharmaceuticals Ltd |
Improvements in or relating to organic materials
|
|
JP2007526329A
(ja)
|
2004-03-04 |
2007-09-13 |
ワイス |
賦形剤の結晶化を改善するための凍結乾燥法
|
|
AU2005249530B2
(en)
|
2004-06-02 |
2012-04-12 |
Victor Bronshtein |
Preservation by vaporization
|
|
WO2006029467A1
(en)
|
2004-09-16 |
2006-03-23 |
Btf Pty Ltd |
Rapid freeze drying process
|
|
KR20070057954A
(ko)
|
2004-09-28 |
2007-06-07 |
알자 코포레이션 |
알룸-애주번트가 있는 면역 활성제의 안정화
|
|
EP1796719B1
(en)
*
|
2004-10-06 |
2014-12-03 |
MedImmune, LLC |
Refrigerator-temperature stable influenza vaccine compositions
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
AU2005304866B2
(en)
*
|
2004-11-05 |
2010-04-01 |
Wellstat Biologics Corporation |
Stable and filterable enveloped virus formulations
|
|
EP1833385B1
(en)
|
2004-12-09 |
2008-08-27 |
Precimed S.A. |
Surgical tool holder for facilitated sterilization
|
|
US20060141483A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Calton Gary J |
Stabilization of viral compositions
|
|
CN103169729A
(zh)
*
|
2005-02-18 |
2013-06-26 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
|
ME01965B
(me)
*
|
2005-09-16 |
2012-04-30 |
Merial Ltd |
Stabilizatori za vakcine osušene zamrzavanjem
|
|
CN1765181A
(zh)
*
|
2005-10-19 |
2006-05-03 |
路兴波 |
高效抗病毒制剂
|
|
PL2007883T3
(pl)
|
2006-04-20 |
2012-07-31 |
Wyeth Llc |
Sposób oczyszczania do izolacji oczyszczonego wirusa pęcherzykowatego zapalenia jamy ustnej z hodowli komórkowej
|
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
EP1854478A1
(en)
|
2006-05-12 |
2007-11-14 |
Cytos Biotechnology AG |
Nicotine-carrier vaccine formulation
|
|
EP1878791A1
(en)
|
2006-07-11 |
2008-01-16 |
Bia Separations D.O.O. |
Method for influenza virus purification
|
|
CA2662569C
(en)
|
2006-08-07 |
2017-01-03 |
Japan As Represented By Director General Of National Institute Of Infectious Diseases |
Process for preparing live smallpox vaccine
|
|
WO2008039761A2
(en)
|
2006-09-25 |
2008-04-03 |
Medimmune, Llc. |
Stabilized antibody formulations and uses thereof
|
|
US20090047255A1
(en)
|
2006-11-03 |
2009-02-19 |
Alphavax, Inc. |
Alphavirus and Alphavirus Replicon Particle Formulations and Methods
|
|
CN101808657A
(zh)
*
|
2006-11-07 |
2010-08-18 |
赛诺菲巴斯德生物制剂公司 |
冻干法稳定疫苗
|
|
ES2951660T3
(es)
*
|
2006-12-27 |
2023-10-24 |
Zoetis Services Llc |
Procedimientos de administración de vacunas
|
|
WO2008106646A2
(en)
|
2007-03-01 |
2008-09-04 |
Introgen Therapeutics, Inc |
Methods and formulations for topical gene therapy
|
|
SG191602A1
(en)
*
|
2007-03-12 |
2013-07-31 |
Oncolytics Biotech Inc |
Reoviruses having modified sequences
|
|
GB0705245D0
(en)
|
2007-03-19 |
2007-04-25 |
Stabilitech Ltd |
Stable biological products
|
|
EP2829282B1
(en)
|
2007-03-22 |
2017-10-25 |
The Regents of The University of Colorado, A Body Corporate |
Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
|
|
HUE031617T2
(en)
|
2007-04-06 |
2017-07-28 |
Takeda Vaccines Inc |
Methods and compositions for live attenuated viruses
|
|
AR066649A1
(es)
|
2007-05-21 |
2009-09-02 |
Oncolytics Biotech Inc |
Reovirus mutantes y metodos de elaboracion y uso de los mismos
|
|
EP2197283B1
(en)
*
|
2007-09-25 |
2013-07-17 |
Aridis Pharmaceuticals |
Formulations for preservation of rota virus
|
|
MX2010003642A
(es)
*
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
|
WO2009056651A1
(en)
|
2007-11-02 |
2009-05-07 |
Cytos Biotechnology Ag |
Angiotensin-carrier formulation
|
|
AU2008321016B2
(en)
|
2007-11-12 |
2013-03-28 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
US8227577B2
(en)
|
2007-12-21 |
2012-07-24 |
Hoffman-La Roche Inc. |
Bivalent, bispecific antibodies
|
|
EP2254554A1
(en)
|
2008-02-25 |
2010-12-01 |
Novavax, Inc. |
Sugar glassified virus like particles (vlps)
|
|
WO2009133413A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Novatech D.O.O. |
Formulation based on micronized clinoptilolite as a therapeutic agent for removal of toxins, bacteria and viruses from organism
|
|
EP2473528B1
(en)
*
|
2009-09-03 |
2014-12-03 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
CA2819236A1
(en)
*
|
2010-12-02 |
2012-06-07 |
Oncolytics Biotech Inc. |
Lyophilized viral formulations
|
|
MX373096B
(es)
|
2010-12-02 |
2020-04-27 |
Oncolytics Biotech Inc |
Formulaciones virales líquidas.
|
|
EA201391605A1
(ru)
*
|
2011-04-29 |
2014-02-28 |
Онколитикс Байотек Инк. |
Способы очистки вирусов с использованием гельпроникающей хроматографии
|
|
JP6065096B2
(ja)
|
2015-12-25 |
2017-01-25 |
ダイキン工業株式会社 |
調湿装置
|